2019-nCoV-Spike突变体对病毒感染性的协作效应
Senbiao Fang1, Chuqi Lei1, Meng Li2
1Hunan Provincial Key Lab on Bioinformatics, School of Computer Science and Engineering, Central South University, Changsha 410083, China.
Computational and structural biotechnology journal
|November 3, 2023
概括
新兴的2019-nCoV突变病毒挑战了流行病控制. 这项研究确定了增强病毒感染性和结合ACE2的关键Spike蛋白突变,有助于未来的药物和疫苗开发.
科学领域:
- 病毒学 病毒学
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 新出现的2019-nCoV突变会带来重大的流行病挑战.
- 了解2019-nCoV-Spike蛋白中的突变对于开发有效的对策至关重要.
- 斯派克蛋白突变的致病机制的特征有助于设计新的疫苗和治疗方法.
研究的目的:
- 调查ACE2与各种2019-nCoV-Spike突变体之间的相互作用模式和结合亲和关系.
- 为了确定增强病毒感染性和ACE2结合的特定突变.
- 为抗病毒药物和疫苗的合理设计提供见解.
主要方法:
- 利用计算方法,包括分子动力学模拟.
- 分析了2019-nCoV-Spike/ACE2接口的晶体结构数据.
- 进行病毒感染测试以验证计算结果.
主要成果:
- 确定了31种关键氨基酸,这些氨基酸有助于病毒感染.
- 发现了8个单一突变,其ACE2结合亲和力明显高于野生类型.
- 发现了60个具有明显增强的结合亲缘关系的多种突变,证实了Y449R和S494R等特定突变的协同作用.
- 通过感染分析验证了Spike/ACE2结合自由能量和病毒感染力之间的强烈关联.
结论:
- 这项研究为2019-nCoV-Spike突变的分子机制提供了关键的见解.
- 这些发现支持加强病毒监测和合理设计向治疗方法.
- 鉴定的突变可以为下一代疫苗和抗病毒策略的开发提供信息.
相关概念视频
00:36Viral Mutations
32.4K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.4K
00:57Viral Recombination
23.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.5K
01:05Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K